Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 208371
Company: RISING

Products on ANDA 208371

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
ABIRATERONE ACETATE	ABIRATERONE ACETATE	250MG	TABLET;ORAL	Prescription	AB	No	No

Approval Date(s) and History, Letters, Labels, Reviews for ANDA 208371

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
02/25/2019	ORIG-1	Approval		STANDARD		Label is not available on this site.

Therapeutic Equivalents for ANDA 208371

ABIRATERONE ACETATE

TABLET;ORAL; 250MG
TE Code = AB

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
ABIRATERONE ACETATE	ABIRATERONE ACETATE	250MG	TABLET;ORAL	Prescription	No	AB	208327	AMNEAL PHARMS
ABIRATERONE ACETATE	ABIRATERONE ACETATE	250MG	TABLET;ORAL	Prescription	No	AB	208453	APOTEX
ABIRATERONE ACETATE	ABIRATERONE ACETATE	250MG	TABLET;ORAL	Prescription	No	AB	208416	DR REDDYS
ABIRATERONE ACETATE	ABIRATERONE ACETATE	250MG	TABLET;ORAL	Prescription	No	AB	209227	GLENMARK SPECLT
ABIRATERONE ACETATE	ABIRATERONE ACETATE	250MG	TABLET;ORAL	Prescription	No	AB	208339	HIKMA
ABIRATERONE ACETATE	ABIRATERONE ACETATE	250MG	TABLET;ORAL	Prescription	No	AB	210686	MSN
ABIRATERONE ACETATE	ABIRATERONE ACETATE	250MG	TABLET;ORAL	Prescription	No	AB	208446	MYLAN
ABIRATERONE ACETATE	ABIRATERONE ACETATE	250MG	TABLET;ORAL	Prescription	No	AB	215947	NOVUGEN
ABIRATERONE ACETATE	ABIRATERONE ACETATE	250MG	TABLET;ORAL	Prescription	No	AB	212462	QILU
ABIRATERONE ACETATE	ABIRATERONE ACETATE	250MG	TABLET;ORAL	Prescription	No	AB	208371	RISING
ABIRATERONE ACETATE	ABIRATERONE ACETATE	250MG	TABLET;ORAL	Prescription	No	AB	208380	WOCKHARDT BIO AG
ZYTIGA	ABIRATERONE ACETATE	250MG	TABLET;ORAL	Prescription	Yes	AB	202379	JANSSEN BIOTECH